XML 24 R3.htm IDEA: XBRL DOCUMENT
v3.26.1

Award Timing Disclosure | 12 Months Ended |
--- | --- | ---
Dec. 31, 2025 | Dec. 22, 2025 USD ($) $ / shares
Award Timing Disclosures [Line Items] |  |
Award Timing MNPI Disclosure | Policies and Practices Related to the Grant of Certain Equity Awards Close in Time to the Release of Material Nonpublic Information From time to time, we grant stock options to employees, including our named executive officers. Also, non-employee directors receive automatic grants of initial and annual stock option awards, at the time of a director’s initial election to the Board and at the time of each annual meeting of the Company’s stockholders, respectively, pursuant to our Director Compensation Plan, as further described under the heading “—Non-Employee Director Compensation Plan” above. We do not otherwise maintain any written policies on the timing of awards of stock options, stock appreciation rights, or similar instruments with option-like features. Neither our Board nor our Compensation Committee takes material non-public information (“MNPI”) about the Company into account when determining the timing of equity awards, nor do we time the disclosure of MNPI for the purpose of impacting the value of executive compensation. The following table is being provided pursuant to Item 402(x)(2) of Regulation S-K.
Name (a) |  | Grant date (b) |  | Number of securities underlying the award (c) |  | Exercise price of the award ($/Share) (d) |  | Grant date fair value of the award ($) (e) (1) |  | Percentage change in the closing market price of the securities underlying the award between the trading day ending immediately prior to the disclosure of material nonpublic information and the trading day beginning immediately following the disclosure of material nonpublic information (%) (f)
Dr. Remy Luthringer |  |  |  | 12/22/2025 | (2) |  |  |  | 2,250,000 |  |  |  |  | 3.98 |  |  |  | $ | 8,190,000 |  |  |  |  | 2.0 | %
Geoffrey Race |  |  |  | 12/22/2025 | (2) |  |  |  | 1,500,000 |  |  |  |  | 3.98 |  |  |  | $ | 5,460,000 |  |  |  |  | 2.0 | %
Frederick Ahlholm |  |  |  | 12/22/2025 | (2) |  |  |  | 500,000 |  |  |  |  | 3.98 |  |  |  | $ | 1,820,000 |  |  |  |  | 2.0 | %
(1) | Amounts represent grant date fair values of the stock options computed in accordance with ASC Topic 718. Assumptions used in valuing options are described in Note 8 to our consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on March 11, 2026. The aggregate grant date fair value does not take into account any estimated forfeitures related to service-vesting conditions. These amounts do not reflect the actual economic value that will be realized by the named executive officers upon the vesting or exercise of the stock options, or the sale of the Common Stock underlying such stock options.
(2) | On December 22, 2025, our Board approved and priced certain equity compensation awards in the form of stock options to our named executive officers, which coincided with a Current Report on Form 8-K announcing the results of our 2025 Annual Meeting.
Award Timing Predetermined | true |
MNPI Disclosure Timed for Compensation Value | false |
Awards Close in Time to MNPI Disclosures, Table | The following table is being provided pursuant to Item 402(x)(2) of Regulation S-K.
Name (a) |  | Grant date (b) |  | Number of securities underlying the award (c) |  | Exercise price of the award ($/Share) (d) |  | Grant date fair value of the award ($) (e) (1) |  | Percentage change in the closing market price of the securities underlying the award between the trading day ending immediately prior to the disclosure of material nonpublic information and the trading day beginning immediately following the disclosure of material nonpublic information (%) (f)
Dr. Remy Luthringer |  |  |  | 12/22/2025 | (2) |  |  |  | 2,250,000 |  |  |  |  | 3.98 |  |  |  | $ | 8,190,000 |  |  |  |  | 2.0 | %
Geoffrey Race |  |  |  | 12/22/2025 | (2) |  |  |  | 1,500,000 |  |  |  |  | 3.98 |  |  |  | $ | 5,460,000 |  |  |  |  | 2.0 | %
Frederick Ahlholm |  |  |  | 12/22/2025 | (2) |  |  |  | 500,000 |  |  |  |  | 3.98 |  |  |  | $ | 1,820,000 |  |  |  |  | 2.0 | %
(1) | Amounts represent grant date fair values of the stock options computed in accordance with ASC Topic 718. Assumptions used in valuing options are described in Note 8 to our consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on March 11, 2026. The aggregate grant date fair value does not take into account any estimated forfeitures related to service-vesting conditions. These amounts do not reflect the actual economic value that will be realized by the named executive officers upon the vesting or exercise of the stock options, or the sale of the Common Stock underlying such stock options.
(2) | On December 22, 2025, our Board approved and priced certain equity compensation awards in the form of stock options to our named executive officers, which coincided with a Current Report on Form 8-K announcing the results of our 2025 Annual Meeting.
Dr Remy Luthringer [Member] |  |
Awards Close in Time to MNPI Disclosures |  |
Name |  | Dr. RemyLuthringer
Underlying Securities |  | 2,250,000
Exercise Price | $ / shares |  | $ 3.98
Fair Value as of Grant Date | $ |  | $ 8,190,000
Underlying Security Market Price Change |  | 0.02
Geoffrey Race [Member] |  |
Awards Close in Time to MNPI Disclosures |  |
Name |  | Geoffrey Race
Underlying Securities |  | 1,500,000
Exercise Price | $ / shares |  | $ 3.98
Fair Value as of Grant Date | $ |  | $ 5,460,000
Underlying Security Market Price Change |  | 0.02
Frederick Ahlholm [Member] |  |
Awards Close in Time to MNPI Disclosures |  |
Name |  | Frederick Ahlholm
Underlying Securities |  | 500,000
Exercise Price | $ / shares |  | $ 3.98
Fair Value as of Grant Date | $ |  | $ 1,820,000
Underlying Security Market Price Change |  | 0.02

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 -Subparagraph ii -Sentence D + Details
Name: | ecd_AwardExrcPrice
Namespace Prefix: | ecd_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 -Subparagraph ii -Sentence E + Details
Name: | ecd_AwardGrantDateFairValue
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | instant

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_AwardTmgDiscLineItems
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_AwardTmgMnpiDiscTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_AwardTmgPredtrmndFlag
Namespace Prefix: | ecd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 -Subparagraph ii -Sentence C + Details
Name: | ecd_AwardUndrlygSecuritiesAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 -Subparagraph ii -Sentence A + Details
Name: | ecd_AwardsCloseToMnpiDiscIndName
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | instant

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 + Details
Name: | ecd_AwardsCloseToMnpiDiscTable
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 + Details
Name: | ecd_AwardsCloseToMnpiDiscTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 1 + Details
Name: | ecd_MnpiDiscTimedForCompValFlag
Namespace Prefix: | ecd_
Data Type: | xbrli:booleanItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection x -Paragraph 2 -Subparagraph ii -Sentence F + Details
Name: | ecd_UndrlygSecurityMktPriceChngPct
Namespace Prefix: | ecd_
Data Type: | xbrli:pureItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | ecd_IndividualAxis=nerv_DrRemyLuthringerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=nerv_GeoffreyRaceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=nerv_FrederickAhlholmMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |